Fig. 6.
miR-301a suppresses invasion of GBM cells in vivo. (A) Tumor growth was measured after treatment with β-catenin siRNA or β-catenin siRNA plus miR-301a mimics. (B) Tumor growth was measured after treatment with As-miR-301a or As-miR-301a plus SEPT7 siRNA. (C, D) Western blot revealed MMP2 and MMP9 levels in different groups.